Iopamiro

Iopamidol, the active ingredient in Iopamiro, is a non‑ionic iodinated contrast agent presented as a solution for injection for intraarterial, intraarticular and intrathecal use. It provides iodine‑based contrast enhancement for X‑ray imaging in diagnostic procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iopamidol is used as a radiographic contrast medium to enhance visualization of vascular and body spaces in imaging procedures. - Angiography: improves vessel delineation for diagnostic and interventional studies. - Arthrography: enhances joint space contrast to assess cartilage and soft‑tissue structures. - Myelography: provides clear delineation of the spinal canal and nerve roots. - Enhanced CT imaging: increases attenuation of X‑rays for superior organ and lesion detection.

Adverse reactions may occur following administration of Iopamiro. Most are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or mild vomiting. - Headache or dizziness. - Transient metallic taste.

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse or hypotension. - Pulmonary edema or bronchospasm. - Seizures or altered mental status.

Iopamiro should be used with careful assessment of patient risk factors and appropriate monitoring. - Renal function assessment: evaluate serum creatinine before administration in at-risk patients. - Allergy history: screen for prior reactions to iodinated contrast agents. - Hydration: ensure adequate fluid intake before and after the procedure to reduce nephrotoxicity. - Concomitant nephrotoxic drugs: consider dose adjustment or alternative imaging. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iopamiro may interact with other agents that affect renal function or hypersensitivity risk.

Major Interactions (Avoid): - High‑dose nephrotoxic antibiotics (e.g., aminoglycosides): increase risk of renal injury. - Loop diuretics combined with dehydration: potentiate contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely): - Metformin: temporarily discontinue in patients with impaired renal function. - Beta‑blockers: may mask signs of contrast‑induced hypertension. - NSAIDs: monitor renal parameters when used concurrently.